170 related articles for article (PubMed ID: 32425386)
41. Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia.
Ren Q; Zhou YL; Wang L; Chen YS; Ma YN; Li PP; Yin XL
Ann Hematol; 2018 Oct; 97(10):1933-1939. PubMed ID: 29931453
[TBL] [Abstract][Full Text] [Related]
42. Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study.
Cappellini MD; Porter J; Origa R; Forni GL; Voskaridou E; Galactéros F; Taher AT; Arlet JB; Ribeil JA; Garbowski M; Graziadei G; Brouzes C; Semeraro M; Laadem A; Miteva D; Zou J; Sung V; Zinger T; Attie KM; Hermine O
Haematologica; 2019 Mar; 104(3):477-484. PubMed ID: 30337358
[TBL] [Abstract][Full Text] [Related]
43. Oxidative Stress (Malondialdehyde) in Adults Beta-Thalassemia Major and Intermedia: Comparison Between Before and After Blood Transfusion and Its Correlation with Iron Overload.
Atmakusuma TD; Nasution IR; Sutandyo N
Int J Gen Med; 2021; 14():6455-6462. PubMed ID: 34675613
[TBL] [Abstract][Full Text] [Related]
44. Economic and clinical burden of managing transfusion-dependent β-thalassemia in the United States.
Udeze C; Evans KA; Yang Y; Lillehaugen T; Manjelievskaia J; Mujumdar U; Li N; Andemariam B
J Med Econ; 2023; 26(1):924-932. PubMed ID: 37432699
[TBL] [Abstract][Full Text] [Related]
45. Clinico-Hematological Profile and Management of Children With Non-Transfusion Dependent Thalassemia (NTDT) at a Pediatric Center in Northern India.
Parakh N; Khan A; Sharma S; Chandra J
Indian Pediatr; 2023 Aug; 60(8):644-647. PubMed ID: 37563885
[TBL] [Abstract][Full Text] [Related]
46. Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO
Taher A; Viprakasit V; Cappellini MD; Sutcharitchan P; Ward R; Mahmoud D; Laadem A; Khan A; Gwaltney C; Harding G; Attie K; Zhang X; Zou J; Pariseau J; Hu XH; Kattamis A
Am J Hematol; 2019 Feb; 94(2):171-176. PubMed ID: 30394579
[TBL] [Abstract][Full Text] [Related]
47. Morbidities in non-transfusion-dependent thalassemia.
Saliba AN; Taher AT
Ann N Y Acad Sci; 2016 Mar; 1368(1):82-94. PubMed ID: 27186941
[TBL] [Abstract][Full Text] [Related]
48. Thalassemia: Common Clinical Queries in Management.
Lal A; Bansal D
Indian J Pediatr; 2020 Jan; 87(1):75-81. PubMed ID: 31620986
[TBL] [Abstract][Full Text] [Related]
49. Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy.
Musallam KM; Taher AT; Kattamis A; Kuo KHM; Sheth S; Cappellini MD
Drug Des Devel Ther; 2023; 17():1583-1591. PubMed ID: 37255740
[TBL] [Abstract][Full Text] [Related]
50. The use of hydroxyurea in the real life of MIOT network: an observational study.
Ricchi P; Meloni A; Rigano P; Pistoia L; Spasiano A; Allò M; Messina G; Quarta A; Rosso R; Quota A; Filosa A; Maggio A; Pepe A
Expert Opin Drug Saf; 2022 Nov; 21(11):1433-1440. PubMed ID: 35435090
[TBL] [Abstract][Full Text] [Related]
51. Clinical Classification, Screening and Diagnosis for Thalassemia.
Viprakasit V; Ekwattanakit S
Hematol Oncol Clin North Am; 2018 Apr; 32(2):193-211. PubMed ID: 29458726
[TBL] [Abstract][Full Text] [Related]
52. Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand.
Chuncharunee S; Teawtrakul N; Siritanaratkul N; Chueamuangphan N
PLoS One; 2019; 14(3):e0214148. PubMed ID: 30893381
[TBL] [Abstract][Full Text] [Related]
53. PREVALENCE AND RISK FACTORS FOR CARDIAC IRON OVERLOAD AND CARDIOVASCULAR COMPLICATIONS AMONG PATIENTS WITH THALASSEMIA IN NORTHERN THAILAND.
Tantiworawit A; Tapanya S; Phrommintikul A; Saekho S; Rattarittamrong E; Norasetthada L; Chai-Adisaksopha C; Hantrakool S; Charoenkwan P; Chattipakorn N
Southeast Asian J Trop Med Public Health; 2016 Nov; 47(6):1335-42. PubMed ID: 29634199
[TBL] [Abstract][Full Text] [Related]
54. The association between pre-transfusion hemoglobin levels and thalassemia complications.
Wanchaitanawong W; Tantiworawit A; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L; Niprapan P; Fanhchaksai K; Charoenkwan P
Hematology; 2021 Dec; 26(1):1-8. PubMed ID: 33357151
[TBL] [Abstract][Full Text] [Related]
55. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management.
Vichinsky E
Curr Med Res Opin; 2016; 32(1):191-204. PubMed ID: 26479125
[TBL] [Abstract][Full Text] [Related]
56. Hypothyroidism in children with Hb E/β-thalassemia compared between those who received regular transfusion and those who underwent hematopoietic stem cell transplantation.
Sriwichakorn C; Nakavachara P; Jitpirasakun S; Pooliam J; Sanpakit K
Pediatr Hematol Oncol; 2023 Feb; 40(1):1-13. PubMed ID: 35499955
[TBL] [Abstract][Full Text] [Related]
57. Key Determinants of Phenotypic Heterogeneity of Hb E/β Thalassemia: A Comparative Study from Eastern India.
Kalantri SA; Ray R; Choudhuri S; Roy S; Bhattacharyya M
Indian J Hematol Blood Transfus; 2020 Jan; 36(1):123-128. PubMed ID: 32158094
[TBL] [Abstract][Full Text] [Related]
58. Blood transfusion therapy for β-thalassemia major and hemoglobin E β-thalassemia: Adequacy, trends, and determinants in Sri Lanka.
Mettananda S; Pathiraja H; Peiris R; Wickramarathne N; Bandara D; de Silva U; Mettananda C; Premawardhena A
Pediatr Blood Cancer; 2019 May; 66(5):e27643. PubMed ID: 30697927
[TBL] [Abstract][Full Text] [Related]
59. Leukocyte telomere length in patients with transfusion-dependent thalassemia.
Nanthatanti N; Tantiworawit A; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L; Tuntiwechapikul W; Fanhchaksai K; Charoenkwan P; Kumfu S; Chattipakorn N
BMC Med Genomics; 2020 Jun; 13(1):73. PubMed ID: 32487251
[TBL] [Abstract][Full Text] [Related]
60. Pregnancy outcomes in women with non-transfusion dependent thalassaemia (NTDT): A haematology centre experience.
Lee BS; Sathar J; Sivapatham L; Lee LI
Malays J Pathol; 2018 Aug; 40(2):149-152. PubMed ID: 30173232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
